The Federal Court has upheld a decision of the Minister of Health (Minister) that the new owner of a biosimilar new drug submission (NDS) could adopt the notice of allegation (NOA) served by its
Judicial review
Federal Court finds that Health Canada breached procedural fairness by relying on an undisclosed internal guidance document



By Kristin Wall, Paul Jorgensen & John Greiss on
On August 8, 2023, the Federal Court overturned Health Canada’s decision that a cannabis product, Edison Jolts, was to be classified as edible cannabis and not cannabis extract. The Court found that Health Canada had breached the duty of procedural…